Factors Associated With the Decay of Anti-SARS-CoV-2 S1 IgG Antibodies Among Recipients of an Adenoviral Vector-Based AZD1222 and a Whole-Virion Inactivated BBV152 Vaccine

BACKGROUND: The magnitude of protection conferred following recovery from COVID-19 or by vaccine administration, and the duration of protective immunity developed, remains ambiguous. METHODS: We investigated the factors associated with anti-SARS-CoV-2 S1 IgG decay in 519 individuals who recovered fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Selvavinayagam, Sivaprakasam T., Yong, Yean Kong, Tan, Hong Yien, Zhang, Ying, Subramanian, Gurunathan, Rajeshkumar, Manivannan, Vasudevan, Kalaivani, Jayapal, Priyanka, Narayanasamy, Krishnasamy, Ramesh, Dinesh, Palani, Sampath, Larsson, Marie, Shankar, Esaki M., Raju, Sivadoss
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235407/
https://www.ncbi.nlm.nih.gov/pubmed/35770011
http://dx.doi.org/10.3389/fmed.2022.887974

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235407/
https://www.ncbi.nlm.nih.gov/pubmed/35770011
http://dx.doi.org/10.3389/fmed.2022.887974

Ejemplares similares